For now, Tesla's well-diversified capability across energy/storage/services are showing robust monetization opportunities ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.

Empire is based at 40 Wall Street, New York, New York, United States of America. Empire has been engaged for a period of three months, effective February 7, 2025 (the “ Empire Agreement ”). Pursuant ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzdTM, signi ...

Hangover Relief: Participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment, and reduced headache compared to ...

Tesla Inc. plans to launch a long-promised robotaxi business and get back to growing vehicle sales after a year of decline in ...

Tesla plans to introduce unsupervised FSD in Austin by June 2025, with a gradual rollout to additional regions and vehicles by year-end. Musk emphasized that safety and regulatory approvals would ...

Supervisory Board Freya Pharma Solutions Freya Pharma’s new Supervisory Board From left to right: Manuel Voll, James E.